Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | P17 - Poster Session 17

Thursday 04/07/22
11:45 AM - 12:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Practice, Policy, and Ethics, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Health Care Disparities, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation
0.00 CME credit
Diversity, Equity, and Inclusion

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM PDT Abstract 9-001 - Anti-hu Associated Encephalomyelitis as a presentation of Primary Extrapulmonary Small Cell Carcinoma of the Small Bowel
Vincent Trung Huu Ngo, MD
11:45 AM - 12:45 PM PDT Abstract 9-002 - A Tale of 2 Leukodystrophies in DOCK8 Deficiency, a Rare Primary Immunodeficiency
Ariane Soldatos, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 9-003 - Neurologic manifestations of Degos disease
Sasha Zivkovic, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 9-004 - Mast cell activation syndrome, Mannose binding lectin, Ehlers-Danlos syndrome, and Neuropsychiatric symptoms.
Ilene S. Ruhoy, MD
11:45 AM - 12:45 PM PDT Abstract 9-006 - Case series: A review of three patients with autonomic dysfunction and positive TS-HDS or FGFR3 antibodies
Raeann Bourscheid, MD
11:45 AM - 12:45 PM PDT Abstract 9-007 - Demonstrating New-onset or Worsened Sudomotor Function post COVID-19.
Aditi Vian Varma-Doyle, MD
11:45 AM - 12:45 PM PDT Abstract 15-001 - Prescription Opioids in Patients With Migraine in Southern Israel: a Retrospective Database Analysis
Matthew Battistini
11:45 AM - 12:45 PM PDT Abstract 15-002 - Unmet Treatment Needs in Migraine Among Those Seeking Care from Neurologists or Headache Specialists: Results of the OVERCOME US study
Robert A. Nicholson, PhD
11:45 AM - 12:45 PM PDT Abstract 15-003 - Perspectives From Members of an Online Community on Their Communications With Health Care Professionals About Migraine Treatment: A Social Listening Analysis
Edward Kim, MD
11:45 AM - 12:45 PM PDT Abstract 15-004 - Migraine Epidemiology in Southern Israel: A Retrospective Database Study
Matthew Battistini
11:45 AM - 12:45 PM PDT Abstract 15-005 - Employability, Work Difficulties and Factors Impacting Chronic Migraine Patients of Hawaii: Results of a Quality Improvement Survey
Michelle Stafford
11:45 AM - 12:45 PM PDT Abstract 15-006 - Direct Health Care Costs of Patients Suffering With Migraine in Southern Israel: a Retrospective Database Analysis
Lynda Krasenbaum
11:45 AM - 12:45 PM PDT Abstract 3-001 - Cerebellar infarcts are associated with a higher frequency of dementia and decreased performance in cognitive domains of memory, attention, and language.
Camilo Bermudez, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 3-002 - Assessing the Impact of Older Driver Visual and Cognitive Impairment on Intersection Stopping Behavior
Guillermo Basulto-Elias, PhD
11:45 AM - 12:45 PM PDT Abstract 3-003 - Improvement of Quality of Life in Individuals with Cognitive Impairment After Spiritual Support Group
William G. Buxton, MD
11:45 AM - 12:45 PM PDT Abstract 3-004 - Bringing Art to Life: Growing Empathy Through Art Therapy, Life Story and Relationships
Daniel C. Potts, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 3-005 - INVOKE-2 - A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer’s Disease
Sam Jackson, MD,Other
11:45 AM - 12:45 PM PDT Abstract 12-001 - Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi-National Registry
Sifat Sharmin, PhD
11:45 AM - 12:45 PM PDT Abstract 12-002 - Early Treatment Can Postpone the Time to Disability Pension in Relapsing-Remitting Multiple Sclerosis
Malthe Faurschou Wandall-Holm, MD
11:45 AM - 12:45 PM PDT Abstract 12-003 - Trajectories of disability and relapse-rate in naïve patients on oral drugs: results from the Italian Multiple Sclerosis Register
Alessia Manni
11:45 AM - 12:45 PM PDT Abstract 12-004 - The Impact of BMI on Brain Volume and Cognitive Function in RRMS: A Secondary Analysis
Aliza Ben-Zacharia, PhD, DNP, ANP
11:45 AM - 12:45 PM PDT Abstract 12-005 - Analysis of Fertility Characteristics in Patients With MS in NARCRMS Registry
Megan Vignos, PhD
11:45 AM - 12:45 PM PDT Abstract 12-006 - Patterns of Healthcare Utilization and Expenditure among People with Multiple Sclerosis in the Age of Disease-Modifying Therapy: An Analysis of Claim Data from a Commercially Insured Population in the United States, 2010-2019
Zongqi Xia, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 12-007 - Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
Tamara Castillo-Trivino, MD, MAS, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-008 - Younger Age at Multiple Sclerosis Onset Is Associated With Worse Outcomes at Age 50
Gauruv Bose, MD
11:45 AM - 12:45 PM PDT Abstract 12-009 - A Practical Approach to Longitudinal Neurological Care of Adults With X-linked Adrenoleukodystrophy and Adrenomyeloneuropathy (X-ALD/AMN)
Alexandra Behar Kornbluh, MD
11:45 AM - 12:45 PM PDT Abstract 12-010 - The Diagnosis and Treatment of Epilepsy in Patients with Multiple Sclerosis: a Case Series from Argentina
Melanie Lara Sanchez, MD
11:45 AM - 12:45 PM PDT Abstract 6-001 - Demographic and Clinical Profiles of Neonates Diagnosed with Spinal Muscular Atrophy (SMA) via the Kentucky Newborn Screening (NBS) Program: A Two-Year Experience
Arpita Lakhotia, MD
11:45 AM - 12:45 PM PDT Abstract 6-002 - Case of a novel genotypic homozygous missense mutation that disrupts oligomerization of SMN protein and causes severe SMA Type 0
Sonia Ann Varghese, MD
11:45 AM - 12:45 PM PDT Abstract 6-003 - RAINBOWFISH: Preliminary Efficacy and Safety Data in Risdiplam-Treated Infants with Presymptomatic SMA
Richard S. Finkel, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 6-004 - The Burden of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in the United States (US): First Results of a Global Survey
Walter *Use 337891 Toro Jimenez, MD,PhD
11:45 AM - 12:45 PM PDT Abstract 6-005 - CSF IL-8 as a potential marker for gene therapy outcomes in Spinal Muscular Atrophy
Sumit Verma, MD
11:45 AM - 12:45 PM PDT Abstract 7-001 - The Development of Phelan-McDermid-specific anchors for the Clinical Global Impression Scales
Elizabeth M. Berry-Kravis, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 7-002 - Decoding Speech from Human Motor Cortex Using an Intracortical Brain Computer Interface
Daniel Rubin, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 1-001 - Gender Discrepancies in Neurologist Compensation
Melissa Yu, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 1-002 - Demographic and Subsequent Funding Trends in the AAN Research Program (1996-2021)
Daniela Arantxa Pimentel Maldonado, MD, MSCR
11:45 AM - 12:45 PM PDT Abstract 1-003 - Examining National Representativeness of the Axon Registry
Andrew M. Wilson, MD, MS, MBA
11:45 AM - 12:45 PM PDT Abstract 1-004 - An Ethical Approach to Detecting Covert Consciousness
Michael Young, MD
11:45 AM - 12:45 PM PDT Abstract 10-001 - Occurrence of cognitive impairment in older adult patients with epilepsy
Jeongyeon Hwang, MD
11:45 AM - 12:45 PM PDT Abstract 10-002 - Patient-reported Outcomes in Mood, Fatigue, Sleep Disturbance, and Disability While on Brivaracetam Treatment: a Prospective Observational Study
Michelle Schoonover, PhD
11:45 AM - 12:45 PM PDT Abstract 10-003 - Time-course of Treatment-emergent Adverse Events Potentially Associated with Behavioral Disorders during Adjunctive Brivaracetam Treatment of Adults with Focal Seizures
Kimford J. Meador, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 10-005 - Preferences and Experiences of Women with Epilepsy Regarding Sexual and Reproductive Health Care
Laura Anne Kirkpatrick, MD
11:45 AM - 12:45 PM PDT Abstract 10-006 - Quality of Life in People with Epilepsy: a Population-Based Study in the Detroit Metropolitan Area
Maryam Jamil Syed, MBBS
11:45 AM - 12:45 PM PDT Abstract 10-007 - Factors Associated with Depression in Epilepsy Patients: a Population-Based Study in the Detroit Metropolitan Area
Maryam Jamil Syed, MBBS
11:45 AM - 12:45 PM PDT Abstract 4-001 - Atypical Pharyngo-Cervico-Brachial Variant of GBS Associated with Covid-19 Antibodies
Butchi Raju Garuda, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 4-002 - Bilateral facial nerve palsy associated with COVID-19 infections.
Karan Hingorani, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 4-003 - Neurosyphilis: a challenging diagnosis
Blibeche Hela
11:45 AM - 12:45 PM PDT Abstract 4-004 - CNS Tuberculosis Mimicking as Neurosarcoidosis: A Diagnostic Quandary
Jacob Lowery, DO
11:45 AM - 12:45 PM PDT Abstract 13-001 - Decreasing Delayed Recognition, Diagnosis, & Treatment of Ischemic Posterior Circulation Strokes in The Emergency Department by Improving Triage Screening in Patients Presenting with Atypical Stroke Symptoms
Haley Ruth Hamer
11:45 AM - 12:45 PM PDT Abstract 13-002 - Developing a Pilot Program to Increase Stroke Education Among Internal Medicine Residents
Gilad Muth, DO
11:45 AM - 12:45 PM PDT Abstract 13-003 - Epidemiological Characteristics of Patients Received Therapeutic Hypothermia Following Acute Ischemic Stroke - a Nationwide Perspective
Greshaben Patel
11:45 AM - 12:45 PM PDT Abstract 13-004 - Acute Ischemic Stroke in Young Adults
Narsis Aminian, MD
11:45 AM - 12:45 PM PDT Abstract 13-005 - Clinical pharmacy services as part of the Telehealth After Stroke Care in an underserved setting: a feasibility study
Imama Ali Naqvi, MD
11:45 AM - 12:45 PM PDT Abstract 13-006 - Inclusion of Asymmetric Bilateral Weakness Optimizes VAN Pre-hospital LVO Triage
Aaisha Mozumder, MD
11:45 AM - 12:45 PM PDT Abstract 13-007 - Evaluation of A Pre-hospital Stroke Assessment’s Ability to Identify Patients with Large Vessel Occlusion (LVO)
Samadhi Thavarajah
11:45 AM - 12:45 PM PDT Abstract 13-008 - Completing the NIHSS Score Prior to CT Scan to Reduce Time to Acute Intervention for Stroke: A Quality Improvement Project
Paige Sutton, MD
11:45 AM - 12:45 PM PDT Abstract 13-009 - Impact of Patient Transfer to an External ICU Hospital for Post-Operative Monitoring after Endovascular Intervention
Ankita Tripathi, MD
11:45 AM - 12:45 PM PDT Abstract 13-010 - Impact of Artificial Intelligence Stroke Software on Detection of LVO Transfer Patients
Irma Nora Duncan, MD
11:45 AM - 12:45 PM PDT Abstract 5-001 - Beliefs about Tourette Syndrome in Adolescent Patients with Tics
Jessica Frey, MD
11:45 AM - 12:45 PM PDT Abstract 5-002 - Mini-Child Tourette Syndrome Impairment Scale Scores in Functional versus Primary Tic Disorders
Travis Larsh, MD
11:45 AM - 12:45 PM PDT Abstract 5-003 - Real-world Experience with Botulinum Toxin A for The Treatment of Hemifacial Spasm: A Study of 1138 Injections
Samantha Anne Gutierrez
11:45 AM - 12:45 PM PDT Abstract 5-004 - Real-world Botulinum Toxin Type A Treatment Patterns in Patients with Spasticity
Patrick J. Gillard, PharmD, MS
11:45 AM - 12:45 PM PDT Abstract 5-005 - Real-world Botulinum Toxin Type A Treatment Patterns in Patients with Cervical Dystonia
Patrick J. Gillard, PharmD, MS
11:45 AM - 12:45 PM PDT Abstract 5-006 - Impact of Disease Severity on Presentation Subtype and OnabotulinumtoxinA Utilization in Patients with Cervical Dystonia: Results from the CD PROBE Completer Population
Pinky Agarwal, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 5-007 - Current Perspectives on the Management of Cervical Dystonia Among Global Clinicians
Kate Merath, PhD
11:45 AM - 12:45 PM PDT Abstract 5-008 - EEG analysis of social cognition in cervical dystonia
Shameer Rafee, MBBS
11:45 AM - 12:45 PM PDT Abstract 2-001 - Deep Learning Can Accurately Distinguish Between True Papilledema and Optic Disc Drusen On Ocular Fundus Photographs
Valerie Biousse, MD
11:45 AM - 12:45 PM PDT Abstract 2-002 - The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON)
Nancy J. Newman, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 2-003 - Neurofilament light chain levels differentiate between ischemic and inflammatory optic neuropathies
Shailee Samir Shah, MD
11:45 AM - 12:45 PM PDT Abstract 2-004 - A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic Neuritis
Jeffrey L. Bennett, MD, PhD, FAAN
11:45 AM - 12:45 PM PDT Abstract 2-005 - Cerebrospinal Fluid Biomarkers in Idiopathic Intracranial Hypertension: An Exploratory SWATH Proteomics analysis.
Awadh K. Pandit
11:45 AM - 12:45 PM PDT Abstract 11-001 - Health Disparities in African American Patients with Multiple Sclerosis: A Retrospective Chart Review Study
Elissa Dykes
11:45 AM - 12:45 PM PDT Abstract 11-002 - Racial differences in trust and risk disclosure preferences among older research volunteers screened for prodromal synucleinopathies
Vikas Kotagal, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 11-003 - Brain Barriers: Elucidating Complex Language-Based Barriers to Neurological Care in Limited-English Proficiency, Refugee, and Immigrant Populations
Alexandra Miner
11:45 AM - 12:45 PM PDT Abstract 11-004 - Improving MD-Patient Communication: Patient satisfaction with communication during neurology outpatient consultation in Cross-Cultural Scenarios
Diana Andino, MD
11:45 AM - 12:45 PM PDT Abstract 11-005 - Racial Differences In Palliative Care Utilization And Impact On Inpatient Mortality Length Stay And Costs Among Patients With Ischemic Stroke
Mohammad Rauf A. Chaudhry, MD, MBBS
11:45 AM - 12:45 PM PDT Abstract 11-006 - The Impact of Race and Ethnicity on Time to Diagnosis of Multiple Sclerosis: Preliminary Results
Jemima Akinsanya, DO
11:45 AM - 12:45 PM PDT Abstract 11-007 - Mitochondrial myopathies diagnosed in adulthood: phenotypic spectrum and long-term outcomes
Grayson Bernard Beecher, MD
11:45 AM - 12:45 PM PDT Abstract 11-008 - Adult Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) Diagnostic Challenge
Jory Liang, MD
11:45 AM - 12:45 PM PDT Abstract 11-009 - DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC) for the Treatment of FSHD
Mark Stahl, MD, PhD
Faculty Disclosures
Pierre Duquette, MD The institution of Dr. Duquette has received research support from Biogen and Genzyme.
John D. England, MD, FAAN Dr. England has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. England has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. England has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
J M. Girard, MD Dr. Girard has nothing to disclose.
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Kimford J. Meador, MD, FAAN The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Mark L. Moster, MD, FAAN Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt.
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophoenix. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH. Dr. Rizzo has a non-compensated relationship as a Chair with ABC that is relevant to AAN interests or activities.
William C. Robertson, Jr., MD No disclosure on file
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Bassem I. Yamout, MD, FAAN Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Pavel Klein, MD, FAAN The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Henrique Ballalai Ferraz, MD Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for FQM. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Zambon. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Frohman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion . Dr. Frohman has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Leigh R. Hochberg, MD, PhD, FAAN The institution of Dr. Hochberg has received research support from Paradromics, Synchron, and Neuralink through the MGH Translational Research Center. Dr. Hochberg has received intellectual property interests from a discovery or technology relating to health care.
David Lacomis, MD, FAAN Dr. Lacomis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. The institution of Dr. Lacomis has received research support from Mitsubishi Tanabe. The institution of Dr. Lacomis has received research support from NIH. Dr. Lacomis has received publishing royalties from a publication relating to health care.
Anne C. Van Cott, MD, FAAN Dr. Van Cott has nothing to disclose.
Robert E. Shapiro, MD, PhD, FAAN Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Shapiro has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for EEOC.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono.
Richard L. Barbano, MD, PhD, FAAN Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oscine. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Barbano has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Revance. The institution of Dr. Barbano has received research support from Vaccinex. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Acadia. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Enrico Silvio Bertini, MD Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Anavex. The institution of Dr. Berry-Kravis has received research support from Rett Syndrome Research Trust. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Orphazyme. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Erydel. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation.
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Maria Pia Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. The institution of Dr. Biousse has received research support from NIH. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Neelum T. Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with AtWHealth . Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with VCU Health.
Mitchell S. V. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. The institution of Dr. Elkind has received research support from BMS-Pfizer Alliance for Eliquis. The institution of Dr. Elkind has received research support from Roche. Dr. Elkind has received publishing royalties from a publication relating to health care. Dr. Elkind has a non-compensated relationship as a Officer with American Heart Association that is relevant to AAN interests or activities.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Daniel C. Potts, MD, FAAN Dr. Potts has received publishing royalties from a publication relating to health care. Dr. Potts has a non-compensated relationship as a President with Cognitive Dynamics Foundation (non-profit) that is relevant to AAN interests or activities.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Bio. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Podoll. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Patterson. The institution of Dr. Bennett has received research support from Novartis. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Heidi L. Henninger, MD Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Henninger has received research support from UCB.
H. A. Jinnah, MD, PhD, FAAN Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Alfredo Sadun, MD Dr. Sadun has received publishing royalties from a publication relating to health care.
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex. The institution of Dr. Gilbert has received research support from PTC Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Eric M. Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Verna R. Porter, MD Dr. Porter has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Claudio Gasperini, MD Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Fiona Evann Costello, MD Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Robert G. Wilson, DO Dr. Wilson has nothing to disclose.
Sean D. Ruland, MD Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Alexandre Prat, MD The institution of Dr. Prat has received research support from CIHR and MSSC.
Joseph T. Giacino, PHD Dr. Giacino has nothing to disclose.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Carmen Calles, MD Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
William G. Buxton, MD Dr. Buxton has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Ovbiagele has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Guillermo Izquierdo Ayuso, MD Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Yara D. Fragoso Yara D. Fragoso has nothing to disclose.
M. Tariq Bhatti, MD Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Sean O'Riordan, MD Dr. O'Riordan has nothing to disclose.
Pinky Agarwal, MD, FAAN Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenx Bio . Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharma. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. An immediate family member of Dr. Agarwal has stock in ACTINIUM PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Aquestive Therapeutics. An immediate family member of Dr. Agarwal has stock in Corcept Therapeutics. An immediate family member of Dr. Agarwal has stock in Catalyst Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in Gevo Inc. An immediate family member of Dr. Agarwal has stock in G1 Therapeutics. An immediate family member of Dr. Agarwal has stock in Marinus Pharnmaceuticals. An immediate family member of Dr. Agarwal has stock in OVID Therapeutics. An immediate family member of Dr. Agarwal has stock in Pieris Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in ASSERTIO HOLDINGS INC . An immediate family member of Dr. Agarwal has stock in BLUEBIRD BIO INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in GALECTO INC . An immediate family member of Dr. Agarwal has stock in GLYCOMIMETICS INC. An immediate family member of Dr. Agarwal has stock in Zevra Therapeutics. An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in MEREO BIOPHARMA GROUP PLC. An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in PHASEBIO PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in PROTALIX BIOTHERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in Puma Biotech. An immediate family member of Dr. Agarwal has stock in Xeris Biopharma. An immediate family member of Dr. Agarwal has stock in Tonix Pharma. An immediate family member of Dr. Agarwal has stock in Spruce Biosciences. An immediate family member of Dr. Agarwal has stock in Cassava Sciences. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Cue Biopharma. An immediate family member of Dr. Agarwal has stock in Caribou Biosciences. An immediate family member of Dr. Agarwal has stock in Capricor Therapeutics. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Passage Bio. An immediate family member of Dr. Agarwal has stock in Sutro Biopharma. An immediate family member of Dr. Agarwal has stock in Karyopharma. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Oncolytic Biotech. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vistagen Therapeutics. An immediate family member of Dr. Agarwal has stock in Tscan Therapeutics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Sun Pharma. The institution of Dr. Agarwal has received research support from Inhibikase.
Jessica Doyle Lee, MD, FAAN Dr. Lee has received personal compensation for serving as an employee of American Academy of Neurology.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Ariane Soldatos, MD, FAAN Dr. Soldatos has nothing to disclose.
Charles R.G. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Gregory J. Esper, MD, MBA, FAAN Dr. Esper has stock in NeuroOne Medical Technologies, Inc. Dr. Esper has stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.
Mohammad A. F. Al-Muhaizea, MD Dr. Al-Muhaizea has nothing to disclose.
Zheng Fan, MD Dr. Fan has nothing to disclose.
Gal Ifergane, MD Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceretrieve. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Ifergane has received research support from Teva.
Luis Brieva Ruiz, MD Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Alessandra Lugaresi, MD Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Damiano Paolicelli Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Allison L. Weathers, MD, FAAN Dr. Weathers has received personal compensation in the range of $500-$4,999 for serving as a CME question writer, interviewer, presenter with American Academy of Neurology. Dr. Weathers has a non-compensated relationship as a Chair, Neurology Adult Steering Board with Epic that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the Meeting Management Committee and Member of the Registry and Quality Informatics Subcommittees with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Vice-Chair, Quality Informatics Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the Registry Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the NCP Editorial Board with American Academy of Neurology that is relevant to AAN interests or activities.
Yoshimi Sogawa, MD Dr. Sogawa has nothing to disclose.
Sydney Cash, MD Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Melissa Yu, MD, FAAN An immediate family member of Dr. Yu has received personal compensation for serving as an employee of CVS/Aetna. The institution of Dr. Yu has received research support from Alzheimer's Association. The institution of Dr. Yu has received research support from Biogen. The institution of Dr. Yu has received research support from Eisai. The institution of Dr. Yu has received research support from Novo Nordisk. The institution of Dr. Yu has received research support from Suven. The institution of Dr. Yu has received research support from AriBio.
John Ney, MD, MPH, FAAN Dr. Ney has received personal compensation for serving as an employee of Surgican Neuromonitoring Associates, PLLC. Dr. Ney has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Ayse Altintas, MD Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Catherine Vignal-Clermont, MD Dr. Vignal-Clermont has nothing to disclose.
Lee Birnbaum, MD Dr. Birnbaum has nothing to disclose.
Irene CM Cortese, MD Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC Pharma. Dr. Cortese has a non-compensated relationship as a scientific advisor with Cellevolve that is relevant to AAN interests or activities.
Teresa Frohman, PA No disclosure on file
Becky Schierman Ms. Schierman has nothing to disclose.
Daniel Reich, MD,PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
Adam Quick, MD The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Vikas Kotagal, MD, FAAN Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Alberto Maud, MD Dr. Maud has nothing to disclose.
Trudy Pang, MD Dr. Pang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stratus an Alliance Company.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Ilaria Pesci No disclosure on file
David A. Evans, MBA Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for NeuroNet GPO. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroNet Pro. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro.
Tawfiq Al-Lahham, MD Dr. Al-Lahham has nothing to disclose.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Neuroderm. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Cleveland Clinic. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Sarah M. Benish, MD, FAAN Dr. Benish has nothing to disclose.
Hamada Hamid Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
J. Alexander Fraser, MD Dr. Fraser has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Ksenija Gorni Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
Joan M. Ohayon Joan M. Ohayon has nothing to disclose.
Timothy Lesnick Timothy Lesnick has received personal compensation for serving as an employee of Mayo Clinic.
Jeffrey Farkas No disclosure on file
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Alexandra Urban, MD, FAAN Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.
William T. Hu, MD, PhD, FAAN No disclosure on file
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Steve Wu, MD The institution of Dr. Wu has received research support from Tourette Association of America.
William R. Meador, MD The institution of Dr. Meador has received research support from PCORI.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Scott Przybelski Scott Przybelski has nothing to disclose.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Zongqi Xia, MD, PhD Dr. Xia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Xia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Octave Biosciences. The institution of Dr. Xia has received research support from Department of Defense. The institution of Dr. Xia has received research support from Genentech/Roche.
Henry Paul Moore, MD Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie . Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC.
Sait Ashina, MD Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Anne R. Davis, MD Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exeltis. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ACLU. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Planned Parenthood Federation of America .
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Maysaa Merhi Basha, MD Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Marco Onofrj, MD Dr. Onofrj has nothing to disclose.
Mariann Polgar-Turcsanyi Mariann Polgar-Turcsanyi has nothing to disclose.
Prashanthi Vemuri, PhD The institution of Dr. Vemuri has received research support from NIH.
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
Rosario Blasco Quilez Rosario Blasco Quilez has nothing to disclose.
Glenn Morrison, PhD Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has received stock or an ownership interest from Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Sohum Desai Mr. Desai has nothing to disclose.
Giacomo Lus Giacomo Lus has nothing to disclose.
Yael Shiloh-Malawsky, MD Dr. Shiloh-Malawsky has nothing to disclose.
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Rohit Ajay Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Ermias Mekonnen Aytenfisu, MD Dr. Aytenfisu has nothing to disclose.
Patrick J. Gillard, PharmD, MS Mr. Gillard has received personal compensation for serving as an employee of AbbVie. Mr. Gillard has stock in AbbVie.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Patrick Yu-Wai-Man Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics.
Mark Stahl, MD, PhD Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Sumit Verma, MD Dr. Verma has nothing to disclose.
Pooia Fattahi, MD Dr. Fattahi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
Roland Dominic Jamora Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Chokri Abdellaziz Mhiri, MD Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Tamara Castillo-Trivino, MD, MAS, FAAN Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Hina N. Dave, MD Dr. Dave has nothing to disclose.
Elizabeth Ivy Harrison, MD Dr. Harrison has nothing to disclose.
Ajay Garg Ajay Garg has nothing to disclose.
Awadh K. Pandit Awadh K. Pandit has nothing to disclose.
Andrew M. Wilson, MD, MS, MBA The institution of Dr. Wilson has received research support from Michael J Fox Foundation. The institution of Dr. Wilson has received research support from AHRQ-PCORI. The institution of Dr. Wilson has received research support from CDC. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Academy of Neurology.
Rebecca Mae Allen No disclosure on file
Ilene S. Ruhoy, MD Dr. Ruhoy has nothing to disclose.
Eduardo Aguera Morales, MD, PhD Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Prem S. Subramanian, MD, PhD The institution of Prem S. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenSight Biologics. The institution of Prem S. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Prem S. Subramanian has received personal compensation in the range of $0-$499 for serving as a Consultant for Invex Therapeutics. The institution of Prem S. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Prem S. Subramanian has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-Ophthalmology Society. Prem S. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. The institution of Prem S. Subramanian has received research support from Horizon Therapeutics. The institution of Prem S. Subramanian has received research support from NIH. The institution of Prem S. Subramanian has received research support from GenSight Biologics. The institution of Prem S. Subramanian has received research support from Santhera Pharmaceuticals . Prem S. Subramanian has received intellectual property interests from a discovery or technology relating to health care. Prem S. Subramanian has received publishing royalties from a publication relating to health care.
Neel N. Shah, MD Dr. Shah has nothing to disclose.
Aysun Soysal, MD Dr. Soysal has nothing to disclose.
Melinda S. Martin, PhD Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
Michelle Kaku, MD Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Shila Azodi, MD Dr. Azodi has nothing to disclose.
Anantha Ramana Vellipuram, MD Dr. Vellipuram has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Robert A. Nicholson, PhD Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Jenifer Dwyer No disclosure on file
Michael Gelfand, MD, PhD Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Consultant for Aquestive. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Dr. Gelfand has received research support from Aquestive. The institution of Dr. Gelfand has received research support from Xenon. The institution of Dr. Gelfand has received research support from Cerevel. The institution of Dr. Gelfand has received research support from UNEEG. The institution of Dr. Gelfand has received research support from Livanova. The institution of Dr. Gelfand has received research support from UCB. The institution of Dr. Gelfand has received research support from SK Pharma. The institution of Dr. Gelfand has received research support from Otsuka.
Jennifer Lauren Orthmann Murphy, MD, PhD Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association.
Elie Naddaf, MD The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from American Neuromuscular Foundation. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro.
Marianne Gerber Marianne Gerber has received personal compensation for serving as an employee of Roche. Marianne Gerber has received stock or an ownership interest from F Hoffmann La Roche .
Alejandro Vargas, MD, MS Dr. Vargas has nothing to disclose.
Alexandra Freeman Alexandra Freeman has nothing to disclose.
Marc Schwartz No disclosure on file
Mohammad-Rauf *USE ID 312142 Chaudhry, MD No disclosure on file
Svetlana Dimova Svetlana Dimova has received personal compensation for serving as an employee of UCB Pharma. Svetlana Dimova has received stock or an ownership interest from UCB Pharma.
Gabriel M. Moreno, MD Dr. Moreno has nothing to disclose.
Butchi Raju Garuda, MD, FAAN Dr. Garuda has nothing to disclose.
Nicole Villemarette-Pittman, PhD The institution of Dr. Villemarette-Pittman has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Villemarette-Pittman has received research support from Acadia Pharma.
Paul Andrew LeLorier Mr. LeLorier has received intellectual property interests from a discovery or technology relating to health care.
Patrizia Sola Patrizia Sola has nothing to disclose.
Michael Graff Fara, MD Dr. Fara has nothing to disclose.
Maria Jose Marques de Sa, Prof Maria Jose Marques de Sa, Prof has nothing to disclose.
Riadh Gouider, MD, FAAN Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Jose Luis Sanchez Menoyo, MD Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
John Liang, MD Dr. Liang has nothing to disclose.
Kelsey Rachel Barrell, MD Dr. Juster-Switlyk has nothing to disclose.
Neisha Patel, MD Dr. Patel has nothing to disclose.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Recai Turkoglu Recai Turkoglu has nothing to disclose.
Rebecca Stainman, MD Dr. Stainman has nothing to disclose.
Anthony J Zagar Anthony J Zagar has received personal compensation for serving as an employee of Eli Lilly.
Audrey Thurm, PhD Dr. Thurm has received personal compensation in the range of $100,000-$499,999 for serving as a Thurm with NIMH.
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
Imama Ali Naqvi, MD Dr. Naqvi has nothing to disclose.
Vimala Sravanthi Vajjala, MBBS Dr. Vajjala has nothing to disclose.
Arpita Lakhotia, MD Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Tachira Tavarez, MD Dr. Tavarez has nothing to disclose.
Gauruv Bose, MD Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Bose has received research support from Multiple Sclerosis Society of Canada.
Daniel Thomas Lackland, PhD An immediate family member of Prof. Lackland has received personal compensation for serving as an employee of Sound Pharmacetical. Prof. Lackland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. Prof. Lackland has received publishing royalties from a publication relating to health care.
Rama Alkhaldi Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Sara Eichau Madueño has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Sara Eichau Madueño has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Sara Eichau Madueño has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sara Eichau Madueño has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sara Eichau Madueño has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck. Sara Eichau Madueño has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Sara Eichau Madueño has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Sara Eichau Madueño has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Sara Eichau Madueño has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Sara Eichau Madueño has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche.
Giovanna De Luca Giovanna De Luca has nothing to disclose.
Jason Peragallo Jason Peragallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for neurodiem.
Kenneth Shindler Kenneth Shindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Noveome Biotherapeutics, Inc. Kenneth Shindler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Noveome Biotherapeutics, Inc.. Kenneth Shindler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Santen Pharmaceuticals, Inc. Kenneth Shindler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms and Insurance Companies. The institution of Kenneth Shindler has received research support from NIH. The institution of Kenneth Shindler has received research support from Mallinckrodt Pharmaceuticals, Inc. The institution of Kenneth Shindler has received research support from Gyroscope Therapeutics, Inc. Kenneth Shindler has received intellectual property interests from a discovery or technology relating to health care. Kenneth Shindler has received publishing royalties from a publication relating to health care.
Laura Navarro Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
Monica Borges No disclosure on file
Richard Reilly, PhD Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for La Caixa Foundation. Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Caixa Foundation, Barcelona, Spain. The institution of Dr. Reilly has received research support from Enterprise Ireland. The institution of Dr. Reilly has received research support from Science Foundation Ireland. The institution of Dr. Reilly has received research support from Health Research Board.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Youssef Sidhom, MD Dr. Sidhom has nothing to disclose.
Cavit Boz, MD Dr. Boz has nothing to disclose.
Anita M. Fletcher, MD Dr. Fletcher has nothing to disclose.
Talabhaktula Sateesh Kumar, MD Dr. Kumar has nothing to disclose.
Cedric Laloyaux, PhD Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Leslie Nelson, PT, MPT, OCS Leslie Nelson, PT, MPT, OCS has received personal compensation for serving as an employee of UT Southwestern Medical Center. Leslie Nelson, PT, MPT, OCS has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Leslie Nelson, PT, MPT, OCS has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Leslie Nelson, PT, MPT, OCS has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Audentes. Leslie Nelson, PT, MPT, OCS has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Inc. Leslie Nelson, PT, MPT, OCS has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock.
Pria Anand, MD Dr. Anand has nothing to disclose.
Kara Jo Swafford, MD Dr. Swafford has nothing to disclose.
Abrar Omar Al-Faraj, MD Dr. Al-Faraj has nothing to disclose.
Shamik Shah, MBBS Dr. Shah has nothing to disclose.
Daniel Rubin, MD, PhD The institution of Dr. Rubin has received research support from AAN. The institution of Dr. Rubin has received research support from Harvard Catalyst. The institution of Dr. Rubin has received research support from NIDCD. The institution of Dr. Rubin has received research support from AHA. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care.
Tracy Tholanikunnel, MD Dr. Tholanikunnel has nothing to disclose.
Shailee Samir Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Susana Sainz de la Maza Susana Sainz de la Maza has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme.
Giuseppe Lucisano, 11766 No disclosure on file
Jennifer A. Roggenbuck, MS, CGC The institution of Ms. Roggenbuck has received research support from Packard Foundation.
Atul T. Patel Atul T. Patel, 15908 has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Atul T. Patel, 15908 has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel, 15908 has received research support from Allergan. The institution of Atul T. Patel, 15908 has received research support from Revance. The institution of Atul T. Patel, 15908 has received research support from IPSEN.
Urvish K Patel Mr. Patel has nothing to disclose.
Celeste Fine Ms. Fine has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Fine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Aliza Ben-Zacharia, PhD, DNP, ANP Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Karen Lundgren Ms. Lundgren has nothing to disclose.
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
Yelena Bodien, PhD Dr. Bodien has nothing to disclose.
Maria Campo Amigo Maria Campo Amigo has nothing to disclose.
Olga Carmona Codina No disclosure on file
Michael Young, MD Dr. Young has nothing to disclose.
Heidemarie Kletzl Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche.
Jemima Akinsanya, DO Dr. Akinsanya has nothing to disclose.
Paige Sutton, MD Dr. Sutton has nothing to disclose.
Grayson Bernard Beecher, MD Dr. Beecher has nothing to disclose.
Irma Nora Duncan, MD Ms. Duncan has nothing to disclose.
Samuel Aballea The institution of Samuel Aballea has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Gene Therapies.
Nouha Farhat No disclosure on file
Mariem Damak No disclosure on file
Sami Elmoufti Sami Elmoufti has nothing to disclose.
Alexandra Behar Kornbluh, MD Dr. Kornbluh has nothing to disclose.
Mariano Marrodan, MD Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Kyle Darpel, MD Dr. Darpel has nothing to disclose.
Laura Anne Kirkpatrick, MD The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital.
Senyene Hunter, MD Dr. Hunter has nothing to disclose.
Thomas Ryan Ford, MD Dr. Ford has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
David Toupin, MD Dr. Toupin has nothing to disclose.
Mohammad Ghatali, MD Dr. Ghatali has nothing to disclose.
Daniela Arantxa Pimentel Maldonado, MD, MSCR Dr. Pimentel Maldonado has nothing to disclose.
Sonesh Dilip Amin, MD Dr. Amin has nothing to disclose.
Camilo Bermudez, MD, PhD Dr. Bermudez has nothing to disclose.
John J. Chen John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John J. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon.
Magali Taiel Magali Taiel has nothing to disclose.
Julio Dotor Garcia-Soto JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Jose-Alain Sahel The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tenpoint . The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Chronolife. Jose-Alain Sahel has stock in VegaVect Inc.. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ". Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care.
Lucía *use 253857 Forero Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche .
Abril Marone, MD Dr. Marone has nothing to disclose.
Michelle A. Farrar Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Danielle Wheelwright Danielle Wheelwright has nothing to disclose.
Mathias Buron Mathias Buron has nothing to disclose.
Raquel T. Brillante, DNP, MSN Dr. Brillante has received personal compensation for serving as an employee of BIOGEN . Dr. Brillante has received stock or an ownership interest from BIOGEN .
Megan Vignos, PhD Dr. Vignos has stock in Biogen. Dr. Vignos has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Biogen.
Nancy Jones Nancy Jones has received personal compensation for serving as an employee of Neuren Pharmaceuticals.
Paola Gazzola Paola Gazzola has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Paola Gazzola has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Raeann Bourscheid, MD Dr. Bourscheid has nothing to disclose.
Samantha Anne Gutierrez Samantha Anne Gutierrez has nothing to disclose.
Diana Andino, MD Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Multiple Sclerosis American Association. Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Andino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Sheela Raghavan Sheela Raghavan has nothing to disclose.
Anam Syed, DO Dr. Syed has nothing to disclose.
Sujani Bandela, MD Dr. Bandela has nothing to disclose.
Sifat Sharmin, PhD Dr. Sharmin has nothing to disclose.
Shubham Misra, PhD Dr. Misra has nothing to disclose.
Aleksej Zuzek, PhD Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Elia Sechi, MD Dr. Sechi has nothing to disclose.
Sara Mariotto, MD, PhD Dr. Mariotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, TSF, Dynamics. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF.
Hrishikesh A. Lokhande Mr. Lokhande has nothing to disclose.
Alexandra *use 101752 Prufer Manickvasagam Janarthanam has nothing to disclose.
Dheeraj Mohania Dheeraj Mohania has nothing to disclose.
Aditi Vian Varma-Doyle, MD Dr. Varma-Doyle has nothing to disclose.
Ibrahima Diouf Ibrahima Diouf has nothing to disclose.
Alexander Kolevzon Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Alexander Kolevzon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics. Alexander Kolevzon has received stock or an ownership interest from Ovid Therapeutics. The institution of Alexander Kolevzon has received research support from AMO Pharma. Alexander Kolevzon has received publishing royalties from a publication relating to health care.
David Merrill David Merrill has nothing to disclose.
Javier *Use 290687 Sotoca No disclosure on file
Salma Sakka Salma Sakka has nothing to disclose.
J. Christina *use 300356 Howell No disclosure on file
Sawsan Daoud Sawsan Daoud has nothing to disclose.
Kristen Lucas Kristen Lucas has nothing to disclose.
Nadia Bouattour No disclosure on file
Tine Iskov Kopp Tine Iskov Kopp has received personal compensation in the range of $500-$4,999 for serving as a Congress participation fee with Biogen.
Traci Kazmerski The institution of Traci Kazmerski has received research support from Cystic Fibrosis Foundation. The institution of Traci Kazmerski has received research support from NIH. Traci Kazmerski has received personal compensation in the range of $5,000-$9,999 for serving as a PEP Trainer with Cystic Fibrosis Foundation.
Amber Peskin, CNS Mrs. Peskin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Mrs. Peskin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Kasim Qureshi, MD Dr. Qureshi has nothing to disclose.
Mung Yan Lin Mung Yan Lin has nothing to disclose.
Anne-Liv Schulz Anne-Liv Schulz has received personal compensation for serving as an employee of UCB. Anne-Liv Schulz has received stock or an ownership interest from UCB.
Maryam Jamil Syed, MBBS Dr. Syed has nothing to disclose.
Caroline Vasseneix Caroline Vasseinex has nothing to disclose.
Izanne Roos Izanne Roos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Izanne Roos has received research support from MSIF-ARSEP. Izanne Roos has received research support from Melbourne Research Scholarship. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Merck. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Roche.
Matthew Battistini Matthew Battistini has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Khadija Sonda Moalla No disclosure on file
Dmitry Vlodavets Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Raj Razdan Raj Razdan has nothing to disclose.
Raymond Najjar Raymond Najjar has nothing to disclose.
Omar Dabbous Omar Dabbous has received personal compensation for serving as an employee of Novartis Gene Therapies. Omar Dabbous has received stock or an ownership interest from Novartis Gene Therapies.
Sarah Heintzman, NP Ms. Heintzman has nothing to disclose.
Shameer Rafee, MBBS Dr. Rafee has nothing to disclose.
Laure Blouin Laure Blouin has received personal compensation for serving as an employee of GenSight Biologics.
Becky Wolf An immediate family member of Ms. Wolf has received personal compensation for serving as an employee of Minnesota Hospital Association.
Travis Larsh, MD Dr. Larsh has nothing to disclose.
Jory Liang, MD Dr. Liang has nothing to disclose.
Narsis Aminian, MD Dr. Aminian has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD, MBBS Dr. Chaudhry has nothing to disclose.
Ankita Tripathi, MD Dr. Tripathi has nothing to disclose.
Elizabeth Fortin No disclosure on file
Xavier Nondonfaz Xavier Nondonfaz has received personal compensation for serving as an employee of UCB . Xavier Nondonfaz has received stock or an ownership interest from UCB.
Charles Malpas Charles Malpas has nothing to disclose.
Jeryl Ritzi Tan yu, MD Dr. yu has nothing to disclose.
Jennifer Merickel Jennifer Merickel has nothing to disclose.
Danielle Spitareli Samia Ben Sassi has nothing to disclose.
Danish Kherani, MD Dr. Kherani has nothing to disclose.
Gopi Seepana No disclosure on file
Soukaina Noor, MD Dr. Noor has nothing to disclose.
Rocio Gomez Rocio Gomez has received personal compensation for serving as an employee of Roche Farma.
Jacob Lowery, DO Dr. Lowery has nothing to disclose.
Alessia Manni Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi genzime. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Sonia Ann Varghese, MD Dr. Varghese has nothing to disclose.
Anna Rachele Thamann, MD Dr. Thamann has nothing to disclose.
Fady Mousa-Ibrahim, DO Dr. Mousa-Ibrahim has nothing to disclose.
Aaisha Mozumder, MD Dr. Mozumder has nothing to disclose.
Jeongyeon Hwang, MD Dr. Hwang has nothing to disclose.
Vincent Trung Huu Ngo, MD Dr. Ngo has nothing to disclose.
Karan Hingorani, MD, PhD Dr. Hingorani has nothing to disclose.
Gilad Muth, DO Dr. Muth has nothing to disclose.
Laurel Officer, MD Dr. Officer has nothing to disclose.
Baljinder Singh, MD Dr. Singh has nothing to disclose.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Carly Marshall, MD No disclosure on file
Isabel Victoria Narvaez- Correa, MD Dr. Narvaez- Correa has nothing to disclose.
Adam Bayne Sarayusa, MD Dr. Sarayusa has nothing to disclose.
Heather Lapidus Glassner Heather Lapidus Glassner has received personal compensation for serving as an employee of MyHealthTeams.
Rinat Ribalov Rinat Ribalov has received personal compensation for serving as an employee of TEVA.
Elizabeth Miller Elizabeth Miller has received publishing royalties from a publication relating to health care.
Christopher Steven Mizenko Mr. Mizenko has nothing to disclose.
Lynda Krasenbaum Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Rachel Gorenflo Rachel Gorenflo has nothing to disclose.
Michel Roux Michel Roux has received personal compensation for serving as an employee of Gensight Biologics.
Elizabeth Johnston Elizabeth Johnston has stock in Eli Lilly.
Edmar Zanoteli Edmar Zanoteli has nothing to disclose.
Michael Ward Michael Ward has received personal compensation for serving as an employee of Alector. Michael Ward has stock in Alector. Michael Ward has received intellectual property interests from a discovery or technology relating to health care. Michael Ward has a non-compensated relationship as a Reviewer with ADDF that is relevant to AAN interests or activities.
Melanie Lara Sanchez, MD Dr. Sanchez has nothing to disclose.
Elizabeth Jalazo Elizabeth Jalazo has received personal compensation in the range of $50,000-$99,999 for serving as a Independent Contractor with Angelman Syndrome Foundation.
Arunakumari Upputuri Arunakumari Upputuri has nothing to disclose.
Anish Patel Anish Patel has nothing to disclose.
Yi *Use 386160 Wang Yi Wang has nothing to disclose.
Prashant Dongre, MD, MBBS Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Renata Scalco Renata SCALCO has received personal compensation for serving as an employee of Roche. Renata SCALCO has received stock or an ownership interest from Roche.
Laura Palfreeman Laura Palfreeman has received personal compensation for serving as an employee of Roche.
Amanda Lien Amanda Lien has received personal compensation for serving as an employee of Verana Health. Amanda Lien has stock in Verana Health.
Ashley Pulido Ashley Pulido has nothing to disclose.
Frances Andrada No disclosure on file
Barbora Malecova, PhD Dr. Malecova has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Malecova has received stock or an ownership interest from Avidity Biosciences.
Sole Gatto, PhD Dr. Gatto has received personal compensation for serving as an employee of Monoceros Biosystems. The institution of an immediate family member of Dr. Gatto has received research support from NIH.
Joanne Young, PhD Ms. Young has nothing to disclose.
Moises Garces Redondo, MD Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Almirall. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Philipp Hadwiger, PhD Dr. Hadwiger has nothing to disclose.
Ana María Alonso Torres, MD Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
David Sala, PhD Dr. Sala has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Sala has received stock or an ownership interest from Avidity Biosciences.
Rachel Johns, PhD Dr. Johns has received personal compensation for serving as an employee of Avidity Biosciences, Inc. Dr. Johns has received stock or an ownership interest from Avidity Biosciences, Inc.
Gulin Erdogan, PhD Dr. Erdogan has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Erdogan has received stock or an ownership interest from Avidity Biosciences.
Adam Pavlicek, PhD Dr. Pavlicek has nothing to disclose.
Martin Koegler, PhD Dr. Koegler has nothing to disclose.
Aristotle Mante Aristotle Mante has nothing to disclose.
Jesus Manuel Martin Martinez Jesus Manuel Martin Martinez has nothing to disclose.
Mariona Hervas Pujol Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Raelle Tagge Raelle Tagge has nothing to disclose.
Pietro Iaffaldano Pietro Iaffaldano has nothing to disclose.
Muhammad Imtiaz Tar, DO Mr. Tar has nothing to disclose.
Chetna Dengri, MD Dr. Dengri has nothing to disclose.
David Pielykh Mr. Pielykh has nothing to disclose.
Malthe Faurschou Wandall-Holm, MD Mr. Wandall-Holm has nothing to disclose.
Syed Nazeer Mahmood, MD Dr. Mahmood has nothing to disclose.
Mohammed Rifat Shaik, MBBS Dr. Shaik has nothing to disclose.
Sogut Turkmen Aksoy, MD Mrs. Aksoy has nothing to disclose.
Yogesh Kothari, MBBS Dr. Kothari has nothing to disclose.
Appala Suman Peela, MD,MBBS Dr. Peela has nothing to disclose.
Greshaben Patel Ms. Patel has nothing to disclose.
Petrice Mostardi Cogswell, MD,PhD Dr. Cogswell has nothing to disclose.
Jae Hyun Lee Mr. Lee has received personal compensation for serving as an employee of AbbVie Inc..
Aakash Baskar Mr. Baskar has nothing to disclose.
Kelly Elaine Jackson, Other Ms. JACKSON has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Rosalie Herings, Other Miss Herings has nothing to disclose.
Darrin Sevier Mr. Sevier has received personal compensation in the range of $50,000-$99,999 for serving as a Employee with Kentucky Department for Public Health.
Ekaterina Hofrenning, Other Miss Hofrenning has nothing to disclose.
Noah Blackstone Reeves, Jr., Other Mr. Reeves has nothing to disclose.
Samadhi Thavarajah Miss Thavarajah has nothing to disclose.
Anne Maitland, MD,PhD No disclosure on file
Walter *Use 337891 Toro Jimenez, MD,PhD Dr. Toro Jimenez has received personal compensation for serving as an employee of Novartis Gene Therapies, Inc.. Dr. Toro Jimenez has received personal compensation for serving as an employee of Astellas. Dr. Toro Jimenez has stock in Novartis.
Gema Rebolleda, PhD,MD Prof. Rebolleda has nothing to disclose.
An-Guor Wang, MD,PhD Prof. Wang has received research support from Gensight Biologics.
Alexandra Miner Miss Miner has nothing to disclose.
Laura Borrega Canelo, Sr., MD Dr. Borrega Canelo has nothing to disclose.
Peter Eric Hauer, Other Mr. Hauer has nothing to disclose.
Francisco Barrero-Hernandez, Sr., MD Dr. Barrero-Hernandez has nothing to disclose.
Edward Kim, MD Dr. Kim has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Kim has stock in Biohaven Pharmaceuticals.
Toni Saldana-King No disclosure on file
John Gamba Mr. Gamba has received personal compensation for serving as an employee of Biogen.
Coraly Perez-Bajandas No disclosure on file
Gabaldon Torres Laura, Jr., Other Mrs. Laura has nothing to disclose.
Nathan C. Grove, Other Mr. Grove has nothing to disclose.
Anne M. Lynch, MD The institution of Prof. Lynch has received research support from NIH/NEI. The institution of Prof. Lynch has received research support from University of Colorado School of Medicine. Dept. Ophthalmology.
Karan Divyam Kawatra, Other Mr. Kawatra has nothing to disclose.
Riccardo Sansone Mr. Sansone has nothing to disclose.
Ruth K. Johnson, Other Miss Johnson has nothing to disclose.
Nehaal Ahmed, Other Mr. Ahmed has nothing to disclose.
Shannon Ashley Merillat, Other Ms. Merillat has received personal compensation for serving as an employee of American Academy of Neurology . Ms. Merillat has received personal compensation for serving as an employee of American College of Physicians. An immediate family member of Ms. Merillat has received personal compensation for serving as an employee of Health Dimensions Group.
Patrick Yalung, MD Dr. Yalung has nothing to disclose.
Tamar Lengil, PhD Dr. Lengil has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Florin Floricel, MD,PhD Dr. Floricel has received personal compensation for serving as an employee of UCB Biosciences GmbH. Dr. Floricel has received stock or an ownership interest from UCB Biosciences GmbH.
Mayera Elizur, MD Dr. Elizur has received personal compensation for serving as an employee of Teva.
Brandie Wagner, PhD Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cystic Fibrosis Foundation. The institution of Dr. Wagner has received research support from NIH.
Luca Bollo, MD Dr. Bollo has nothing to disclose.
Jessica *Use 389572 Cirillo, Other Mrs. Cirillo has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Mrs. Cirillo has received stock or an ownership interest from Biohaven Pharmaceuticals.
Elissa Dykes Miss Dykes has nothing to disclose.
Michael Meyers, MD Dr. Meyers has nothing to disclose.
Olivia Stransky, Other Ms. Stransky has nothing to disclose.
Surachat Ngorsuraches, PhD Prof. Ngorsuraches has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche, Thailand. The institution of Prof. Ngorsuraches has received research support from Bristol Meyer Squibb.
Zachary Langston, Other Mr. Langston has nothing to disclose.
Swati Phuljhele, MD Dr. Phuljhele has nothing to disclose.
Gyaninder Pal Singh, Other,MD Dr. Singh has nothing to disclose.
Blibeche Hela Dr. Hela has nothing to disclose.
Wen Zhu, MD Dr. Zhu has nothing to disclose.
Haley Ruth Hamer Ms. Hamer has nothing to disclose.
Anastasiia Motrunich, PhD Dr. Motrunich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis.
Isabelle Havis Ms. Havis has nothing to disclose.
Shannon Sternberg, RN Ms. Sternberg has nothing to disclose.
Steffen Hamann, MD,PhD Dr. Hamann has received publishing royalties from a publication relating to health care.
Yijie Liao, PhD Dr. Liao has received personal compensation for serving as an employee of Alector. Dr. Liao has received stock or an ownership interest from Alector.
Joan DuPont, Other Ms. DuPont has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IVERIC.
Hanlin Li, Other Dr. Li has nothing to disclose.
Clare Louise Fraser, MBBS Dr. Fraser has nothing to disclose.
Malvin Janal, PhD Dr. Janal has nothing to disclose.
Christopher John Cantrell Mr. Cantrell has nothing to disclose.
Shauna Hallmark, PhD Dr. Hallmark has nothing to disclose.
Tien Y. Wong, MD The institution of Prof. Wong has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bayer. The institution of Prof. Wong has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Novartis. The institution of Prof. Wong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Prof. Wong has received intellectual property interests from a discovery or technology relating to health care. Prof. Wong has received intellectual property interests from a discovery or technology relating to health care.
Abraham Brody, PhD,RN,NP Dr. Brody has nothing to disclose.
Sandeep Valluripalli Soorya, PhD Dr. Soorya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Soorya has received stock or an ownership interest from Argus Cognitive, Inc.. Dr. Soorya has received publishing royalties from a publication relating to health care.
Ian Kronish, MD Dr. Kronish has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Cardiology Report. The institution of Dr. Kronish has received research support from National Institutes for Health. The institution of Dr. Kronish has received research support from Agency for Healthcare Research and Quality.
Kanchalika Sathianvichitr, MD Dr. Sathianvichitr has nothing to disclose.
Vanessa Pabon Ms. Pabon has nothing to disclose.
Dan Milea, MD,PhD The institution of Prof. Milea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optomed. The institution of Prof. Milea has received research support from NMRC Singapore.
Vaneet Arora, MD Dr. Arora has nothing to disclose.
Alexander Asamoah, MD,PhD Dr. Asamoah has nothing to disclose.
Mihae Kim, NP Miss Km has nothing to disclose.
Triveni Abburi, MD Dr. Abburi has nothing to disclose.
Kelsey Perry, Other Ms. Perry has nothing to disclose.
Michelle Stafford Miss Stafford has nothing to disclose.
Kahtan Fadah, DO Dr. Fadah has nothing to disclose.
Traci Richelle Lyon, Other Dr. Lyon has nothing to disclose.
Frances Tiffany Morden Miss Morden has nothing to disclose.
Isabelle Messina Miss Messina has nothing to disclose.
Anne C. Galbraith, Other Ms. Galbraith has nothing to disclose.
Deeya Modhwadiya Miss Modhwadiya has nothing to disclose.
Margie Campbell, IV, RN Mrs. Campbell has nothing to disclose.
Rebecca M. Summit, Other Ms. Summit has nothing to disclose.
Alice L. Dawson, Other Ms. Dawson has received research support from Rutgers University.
Kevin Strobino Mr. Strobino has nothing to disclose.
Jessica LeClair Miss LeClair has received research support from The National Institute of General Medical Sciences (NIGMS) Interdisciplinary Training Grant for Biostatisticians (T32 GM74905).
Anastasia Kapitonava Miss Kapitonava has nothing to disclose.
Daniel Mercer, Other Mr. Mercer has received personal compensation for serving as an employee of Genesis Research.
Sonya Borrero, MD The institution of Dr. Borrero has received research support from NIH. The institution of Dr. Borrero has received research support from National Institute for Reproductive Health .
Carolyn Fisher, Other Mrs. Fisher has nothing to disclose.
Claudia Wong, NP Ms. Wong has nothing to disclose.
Guillermo Basulto-Elias, PhD Dr. Basulto-Elias has nothing to disclose.
Felix Leejia Yeh, PhD Dr. Yeh has received stock or an ownership interest from Alector. Dr. Yeh has received stock or an ownership interest from Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist with Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Head of Biomarkers with Alector.
Jennifer Leigh Lisenby Mrs. Lisenby has received personal compensation for serving as an employee of OPICA.
Heather Simpson, Other Dr. Simpson has received personal compensation for serving as an employee of Tourette Association of America. Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tourette Association of America.
Aashka Joshi Ms. Joshi has received personal compensation for serving as an employee of Alector. Ms. Joshi has received personal compensation for serving as an employee of Acerta Pharma. Ms. Joshi has received stock or an ownership interest from Alector.
Angel *use 361259 Duncan, PhD Prof. Duncan has nothing to disclose.
Tracy Van, Other Miss Van has nothing to disclose.
Sam Jackson, MD,Other Dr. Jackson has received personal compensation for serving as an employee of Alector . Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Headland Strategy. Dr. Jackson has stock in Alector and other companies engaged in the business of drug development. .
Matthew Onorato Mr. Onorato has nothing to disclose.
Abe Castro, Other Mr. Castro has nothing to disclose.
Kara Ushijima Miss Ushijima has nothing to disclose.
John D. Simeral, PhD Dr. Simeral has received research support from Office of Research and Development, Rehabilitation R&D Service, Department of Veterans Affairs. Dr. Simeral has received research support from National Institutes of Health (NIDCD, NINDS).
William M. Flanagan, PhD Dr. Flanagan has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Flanagan has received stock or an ownership interest from Avidity Biosciences.
Ron Maor Mr. Maor has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Garineh Mary Melikian Ms. Melikian has received personal compensation for serving as an employee of Avidity Biosciences, Inc.. Ms. Melikian has received stock or an ownership interest from Avidity Biosciences, Inc.
Daniel Gratie, Other Dr. Gratie has received personal compensation for serving as an employee of AESARA, a consulting agency which has conducted contracted research on behalf of AbbVie.
Mehret Birru, MD Dr. Birru has nothing to disclose.
Nabilah Alibhai, Other Mr. Alibhai has received personal compensation for serving as an employee of AbbVie.
Stephanie Standal, MD Dr. Standal has nothing to disclose.
Kate Merath, PhD Dr. Merath has received personal compensation for serving as an employee of Allegan/AbbVie.
Mariya Abayev The institution of Ms. Abayev has received research support from Teva Pharmaceuticals.
Iso Peles The institution of Mr. Peles has received research support from Teva Pharmaceuticals.
Michal Gordon The institution of Mr. Gordon has received research support from Teva Pharmaceuticals.
Victor Novack The institution of Mr. Novack has received research support from Teva Pharmaceuticals.
Mohnnad Asla Mr. Asla has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for medison.
Uiyeol Yoon, RN Mr. Yoon has nothing to disclose.
Ashley Ung, Other Miss Ung has nothing to disclose.
Praveen Singh, Other Mr. Singh has nothing to disclose.
Rahul Chakraborty, Sr., PhD Mr. Chakraborty has nothing to disclose.
Emma Sage Inouye Ms. Inouye has nothing to disclose.
Erwann Ventre, PhD Dr. Ventre has received personal compensation for serving as an employee of CYTOO.
Arthur A. Levin, PhD,PT Dr. Levin has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Levin has received stock or an ownership interest from Avidity Biosciences.
Fiadhnait O'Keeffe, PhD Dr. O'Keeffe has nothing to disclose.
Michael Machiorlatti, PhD,PA Mr. Machiorlatti has nothing to disclose.
Orsolya Kiraly Dr. Kiraly has received personal compensation for serving as an employee of The Jackson Laboratory.
Jaclyn Klepper, PhD Dr. Klepper has nothing to disclose.
Yuliya Baratt, PharmD, BCPS Dr. Baratt has nothing to disclose.
Ashirwad Barnwal Mr. Barnwal has nothing to disclose.
AG Matera, PhD The institution of Prof. Matera has received research support from US National Institutes of Health.
Isabelle Brock, MD Dr. Brock has nothing to disclose.
Zhiqun Tang, PhD Dr. Tang has nothing to disclose.
Cynthia Marion Powell, MD The institution of Dr. M Powell has received research support from NIH. Dr. M Powell has received personal compensation in the range of $500-$4,999 for serving as a Advisory Committee Chair with HRSA.
Anuj Sharma, PhD Dr. Sharma has received personal compensation for serving as an employee of ETALYC Inc. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quality Count. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Sharma has received stock or an ownership interest from ETALYC Inc. The institution of Dr. Sharma has received research support from Federal Highway Administration. The institution of Dr. Sharma has received research support from Iowa DOT. The institution of Dr. Sharma has received research support from Nebraska DOT. The institution of Dr. Sharma has received research support from National Science Foundation.
Bart Peter Leroy, MD, PhD Prof. LEROY has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akouos. The institution of Prof. LEROY has received research support from Novartis. The institution of Prof. LEROY has received research support from GenSight Therapeutics.
Amit Munshi Sharma, MD Dr. Sharma has nothing to disclose.
Renu Renu, Jr., MBBS No disclosure on file
Rudrani Banik Rudrani Banik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guardion Health Sciences. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Healthy Directions. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for USAG NY. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple legal firms for IMEs. The institution of Rudrani Banik has received research support from Regenera. The institution of Rudrani Banik has received research support from Quark Pharmaceuticals.
Kheireddine Ben Mahfoudh No disclosure on file
Keisha Carden No disclosure on file
Angela Crutcher No disclosure on file
Sean Donahue Sean Donahue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensight.
Corina Gonzalez Corina Gonzalez has nothing to disclose.
Tommy Hosman No disclosure on file
Yosra Mzid No disclosure on file
Satish Tadepalli No disclosure on file
Sainan Wei No disclosure on file
Judy Weintraub No disclosure on file
Michelle Schoonover, PhD No disclosure on file